Gut check: your microbiome may predict arthritis drug success
NCT ID NCT04899154
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether the types of bacteria in your gut can predict how well you will respond to biologic drugs for spondyloarthritis, a group of inflammatory conditions affecting the spine and joints. Researchers will compare the gut bacteria of 80 people starting biotherapy and see if certain bacteria patterns are linked to better treatment outcomes. The goal is to help doctors choose the right treatment from the start, avoiding trial-and-error.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPONDYLOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Européen Marseille
RECRUITINGMarseille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Can group learning make biotherapy safer for arthritis patients?
- Gentle tai chi may get spondyloarthritis patients moving
- Immune clues in the blood may foretell heart trouble
- Can a 4-Minute chat rival a Dietitian's hour for heart health?
- Could low vitamin c explain lingering pain in rheumatism and lupus?